Cite
399P Real-world insights into patients (pts) with advanced NSCLC and MET alterations.
MLA
Bittoni, M., et al. “399P Real-World Insights into Patients (Pts) with Advanced NSCLC and MET Alterations.” Annals of Oncology, vol. 31, Nov. 2020, pp. S1398–99. EBSCOhost, https://doi.org/10.1016/j.annonc.2020.10.393.
APA
Bittoni, M., Yang, J. .-H., Shih, J.-Y., Peled, N., Smit, E., Camidge, R., Carbone, D., Oksen, D., Boutmy, E., Johne, A., & Paik, P. (2020). 399P Real-world insights into patients (pts) with advanced NSCLC and MET alterations. Annals of Oncology, 31, S1398–S1399. https://doi.org/10.1016/j.annonc.2020.10.393
Chicago
Bittoni, M., J.C-H. Yang, J-Y. Shih, N. Peled, E. Smit, R. Camidge, D. Carbone, et al. 2020. “399P Real-World Insights into Patients (Pts) with Advanced NSCLC and MET Alterations.” Annals of Oncology 31 (November): S1398–99. doi:10.1016/j.annonc.2020.10.393.